Symptoms of undermedication Less commonly, some patients may experience worsened hypothyroid symptoms if tirzepatide causes enough gastrointestinal disruption, through severe nausea or vomiting, to reduce their levothyroxine absorption on certain days
Try to stay calm and take deep breaths
Whilst the theoretical benefits of GLP-1 receptor agonists in inflammatory conditions are being explored in research settings, patients considering this approach must understand both the potential advantages and significant risks associated with off-label use
Conflict of interest BA has received fees for lecturing or participating in advisory boards from Novartis, Merck, Boehringer Ingelheim, Takeda, Astra Zeneca, Novo Nordisk, Sanofi and GSK, which are companies developing and producing DPP-4 inhibitors or GLP-1 receptor agonists